151 related articles for article (PubMed ID: 15182430)
1. Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated genes.
Yoshida N; Omoto Y; Inoue A; Eguchi H; Kobayashi Y; Kurosumi M; Saji S; Suemasu K; Okazaki T; Nakachi K; Fujita T; Hayashi S
Cancer Sci; 2004 Jun; 95(6):496-502. PubMed ID: 15182430
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 expression in breast cancer.
Mita K; Zhang Z; Ando Y; Toyama T; Hamaguchi M; Kobayashi S; Hayashi S; Fujii Y; Iwase H; Yamashita H
Jpn J Clin Oncol; 2007 Aug; 37(8):575-82. PubMed ID: 17675285
[TBL] [Abstract][Full Text] [Related]
3. HDAC6 expression is correlated with better survival in breast cancer.
Zhang Z; Yamashita H; Toyama T; Sugiura H; Omoto Y; Ando Y; Mita K; Hamaguchi M; Hayashi S; Iwase H
Clin Cancer Res; 2004 Oct; 10(20):6962-8. PubMed ID: 15501975
[TBL] [Abstract][Full Text] [Related]
4. 3-Dimensional microarray analysis of estrogen signal-related genes in breast cancer tissues.
Matsumoto M; Sakamoto H; Yamaguchi Y; Seino Y; Takei H; Kurosumi M; Sasano H; Yaegashi N; Hayashi S
Anticancer Res; 2009 Oct; 29(10):3971-5. PubMed ID: 19846938
[TBL] [Abstract][Full Text] [Related]
5. The immunohistochemical expression and potential prognostic value of HDAC6 and AR in invasive breast cancer.
Li C; Cao L; Xu C; Liu F; Xiang G; Liu X; Jiao J; Niu Y
Hum Pathol; 2018 May; 75():16-25. PubMed ID: 29180246
[TBL] [Abstract][Full Text] [Related]
6. Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features.
Rocha RL; Hilsenbeck SG; Jackson JG; Lee AV; Figueroa JA; Yee D
J Natl Cancer Inst; 1996 May; 88(9):601-6. PubMed ID: 8609661
[TBL] [Abstract][Full Text] [Related]
7. Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers.
Yau C; Benz CC
Breast Cancer Res; 2008; 10(4):R61. PubMed ID: 18631401
[TBL] [Abstract][Full Text] [Related]
8. The expression of insulin receptor substrate 1 and estrogen receptor as prognostic factor on breast cancer patient.
Kim HG; Woo SU; Kim HY; Son GS; Lee JB; Bae JW; Woo OH; Yang DS; Seo JH; Kim AR
J Cancer Res Ther; 2018 Jun; 14(Supplement):S494-S498. PubMed ID: 29970713
[TBL] [Abstract][Full Text] [Related]
9. Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer.
Saji S; Kawakami M; Hayashi S; Yoshida N; Hirose M; Horiguchi S; Itoh A; Funata N; Schreiber SL; Yoshida M; Toi M
Oncogene; 2005 Jun; 24(28):4531-9. PubMed ID: 15806142
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
[TBL] [Abstract][Full Text] [Related]
11. HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.
Elledge RM; Green S; Ciocca D; Pugh R; Allred DC; Clark GM; Hill J; Ravdin P; O'Sullivan J; Martino S; Osborne CK
Clin Cancer Res; 1998 Jan; 4(1):7-12. PubMed ID: 9516946
[TBL] [Abstract][Full Text] [Related]
12. Accurate Estrogen Receptor Quantification in Patients with Negative and Low-Positive Estrogen-Receptor-Expressing Breast Tumors: Sub-Analyses of Data from Two Clinical Studies.
Dixon JM; Cameron DA; Arthur LM; Axelrod DM; Renshaw L; Thomas JS; Turnbull A; Young O; Loman CA; Jakubowski D; Baehner FL; Singh B
Adv Ther; 2019 Apr; 36(4):828-841. PubMed ID: 30859501
[TBL] [Abstract][Full Text] [Related]
13. FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients.
Rangel N; Fortunati N; Osella-Abate S; Annaratone L; Isella C; Catalano MG; Rinella L; Metovic J; Boldorini R; Balmativola D; Ferrando P; Marano F; Cassoni P; Sapino A; Castellano I
BMC Cancer; 2018 Jul; 18(1):703. PubMed ID: 29970021
[TBL] [Abstract][Full Text] [Related]
14. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW
Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435
[TBL] [Abstract][Full Text] [Related]
15. Basic research for hormone-sensitivity of breast cancer.
Hayashi S; Yamaguchi Y
Breast Cancer; 2006; 13(2):123-8. PubMed ID: 16755105
[TBL] [Abstract][Full Text] [Related]
16. Estrogen signaling and prediction of endocrine therapy.
Hayashi S; Yamaguchi Y
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():27-31. PubMed ID: 16273356
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptors (ER) in human breast cancer. The significance of a new prognostic factor based on both ER protein and ER mRNA contents.
Gotteland M; May E; May-Levin F; Contesso G; Delarue JC; Mouriesse H
Cancer; 1994 Aug; 74(3):864-71. PubMed ID: 7913659
[TBL] [Abstract][Full Text] [Related]
18. BRAF/MEK Pathway is Associated With Breast Cancer in ER-dependent Mode and Improves ER Status-based Cancer Recurrence Prediction.
Liu D; Zhou K
Clin Breast Cancer; 2020 Feb; 20(1):41-50.e8. PubMed ID: 31547956
[TBL] [Abstract][Full Text] [Related]
19. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.
Cheang MC; Treaba DO; Speers CH; Olivotto IA; Bajdik CD; Chia SK; Goldstein LC; Gelmon KA; Huntsman D; Gilks CB; Nielsen TO; Gown AM
J Clin Oncol; 2006 Dec; 24(36):5637-44. PubMed ID: 17116944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
